Highlights Bioxyne Limited

Equities

BXN

AU000000BXN6

Market Closed - Australian S.E. Other stock markets 05:30:08 21/05/2024 am IST			5-day change	1st Jan Change
0.006 ^AUD	0.00%		-14.29%	-45.45%

14/05	Bioxyne to Release Shares from Escrow; Shares Up 17%	MT
14/05	Bioxyne Subsidiary, CY Biopharma Enter Partnership to Advance Novel Psilocybin Therapies in Australia	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Bioxyne to Release Shares from Escrow; Shares Up 17%	14/05	MT
Bioxyne Subsidiary, CY Biopharma Enter Partnership to Advance Novel Psilocybin Therapies in Australia	14/05	MT
Bioxyne Limited Reports Earnings Results for the Half Year Ended December 31, 2023	29/02	CI
Bioxyne Receives License to Manufacture Medical Cannabis, MDMA; Shares Up 50%	05/02	MT
Bioxyne Limited Reports Earnings Results for the Full Year Ended June 30, 2023	31/23/31	CI
Bioxyne Unit Joins Forces to Launch B2B Cannabis Trading Platform in Australia; Shares Slump 11%	15/23/15	MT
Bioxyne Limited Extends Amazon Footprint into US and Japan	17/23/17	CI
Bioxyne Acquires Breathe Life Sciences	22/23/22	MT
Bioxyne Limited acquired Breathe Life Sciences Pty Ltd.	19/23/19	CI
Bioxyne Proceeds With Breathe Life Sciences Acquisition; Shares Fall 4%	20/23/20	MT
Bioxyne Limited Reports Earnings Results for the Half Year Ended December 31, 2022	23/23/23	CI
Bioxyne to Acquire Health, Wellness Peer Breathe Life Sciences; Shares Gain 4%	19/22/19	MT
Bioxyne Limited entered into a binding term Sheet to acquire Breathe Life Sciences Pty Ltd for AUD 32 million.	19/22/19	CI
Bioxyne Sells 49% Stake in Direct Selling Business	24/22/24	MT
Paramount Star Investments Limited reached agreement to acquire 49% of Direct Selling Business of Bioxyne Limited from Bioxyne Limited for $1 million.	24/22/24	CI
Bioxyne Limited Reports Earnings Results for the Full Year Ended June 30, 2022	30/22/30	CI
Bioxyne Limited Reports Earnings Results for the Half Year Ended December 31, 2021	22/22/22	CI
Bioxyne's Revenue Surges 12% in Half-Year Ended Dec. 31, 2021	31/22/31	MT
Bioxyne Nixes Potential Acquisition	04/21/04	MT
Bioxyne Limited Reports Earnings Results for the Full Year Ended June 30, 2021	31/21/31	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Bioxyne Limited

Equities

BXN

AU000000BXN6

Highlights

Filters